Eclipse Therapeutics' Debt Round

Eclipse Therapeutics raised a round of funding on April 18, 2011. Investors include City Hill Ventures.

Eclipse Therapeutics is a biotechnology company focused on developing therapeutic product candidates that target cancer stem cells in oncology. Eclipse is a spin-out from Biogen Idec's oncology franch…

Articles about Eclipse Therapeutics' Debt Round: